Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target SNCG (clone 2EC3). We employs the Lentivirus (EF1α-GFP-c-Fos-XbaI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
SNCG
Clone
2EC3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
Lentivirus
Transformation Accuracy
0.88
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.